China’s new cancer drug Toripalimab is approved in the US but will cost 30 times more

US$280 in China, US$8,892 in the US: new Chinese cancer drug gets FDA approval

China’s new cancer drug is approved in the US but will cost 30 times more: US$280 in China, US$8,892 in the US